Abiopharma

News list

Director GRAE SETH 🟢 acquired 78.9K shares (2 derivative) of LIGHTBRIDGE Corp (LTBR) at $18.48 Transaction Date: Aug 06, 2026 | Filing ID: 000339

Full text

News bot Aug. 7, 2026, 8:38 p.m.
🔍 GRAE SETH (Director)

Company: LIGHTBRIDGE Corp (LTBR)

Report Date: 2026-08-06
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 2
- Holdings reported: 2
- Total shares acquired: 105,000
- Total shares held: 26,136
Detailed Transactions and Holdings:
- Acquired 105,000 shares of Common Stock (Direct)
  Date: 2026-08-06 | Code: A | equity_swap_involved: 0 | shares_owned_after: 883,014.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 7,937 shares of Employee Stock Option (right to buy) at $12.6 per share (Derivative)
  Date: 2026-08-06 | Code: H | Expires: 2027-10-26 | shares_owned_after: 7,937.00 | Footnotes: F2
- Holds 18,199 shares of Employee Stock Option (right to buy) at $18.48 per share (Derivative)
  Date: 2026-08-06 | Code: H | Expires: 2026-11-09 | shares_owned_after: 18,199.00 | Footnotes: F2
Footnotes:
- F1: Represents a grant of restricted stock awards (RSAs). These RSAs vest in six equal semi-annual installments over a three-year period, starting on the first semi-annual anniversary of the grant date, contingent on the reporting person's continued service on each such vesting date.
- F2: This option is fully vested as of the date of this report.